When exploring treatment options for depression, two medications come up in conversation more than almost any other: Wellbutrin and Lexapro. Both are widely prescribed, well-studied, and effective — but they work in fundamentally different ways. Understanding the differences between Wellbutrin vs Lexapro can help you have a more informed discussion with your psychiatrist about which option may be the right fit for your symptoms, lifestyle, and treatment goals.
Wellbutrin (bupropion) and Lexapro (escitalopram) belong to entirely different classes of antidepressants. Wellbutrin is a norepinephrine-dopamine reuptake inhibitor (NDRI), while Lexapro is a selective serotonin reuptake inhibitor (SSRI). This distinction matters because the neurotransmitters each medication targets shape everything from the conditions it treats best to the side effects you may experience.
Here is a quick comparison of the two medications:
Wellbutrin, known generically as bupropion, is classified as a norepinephrine-dopamine reuptake inhibitor (NDRI). It works by blocking the reabsorption of two key neurotransmitters — dopamine and norepinephrine — allowing more of each to remain active in the brain.
Dopamine plays a central role in motivation, reward, and pleasure. Norepinephrine is involved in alertness, concentration, and energy. By increasing the availability of both, Wellbutrin can improve focus, drive, and overall mood without heavily influencing serotonin — a distinction that sets it apart from most other antidepressants on the market.
Wellbutrin is available in immediate-release, sustained-release (SR), and extended-release (XL) formulations. The XL version is the most commonly prescribed because it allows for once-daily dosing and tends to produce fewer peaks and valleys in blood levels throughout the day.
Lexapro, or escitalopram, is a selective serotonin reuptake inhibitor (SSRI). It works by blocking the reuptake of serotonin in the brain, which increases the amount of serotonin available in the synaptic space between neurons.
Serotonin is a neurotransmitter that helps regulate mood, sleep, appetite, and emotional processing. When serotonin levels are low or serotonin signaling is disrupted, symptoms of depression and anxiety can emerge. By keeping more serotonin active, Lexapro helps stabilize mood and reduce the intensity of anxious or depressive thoughts.
Lexapro is considered one of the most selective SSRIs available, meaning it has fewer off-target effects than older medications in the same class. It is typically taken once daily, and most patients begin to notice improvements within two to four weeks of starting treatment.
Although both Wellbutrin and Lexapro are used for depression, their FDA-approved indications and clinical strengths differ in important ways.
Wellbutrin is FDA-approved for:
Wellbutrin is also frequently used off-label to support weight management and to address symptoms of attention-deficit/hyperactivity disorder (ADHD) in adults.
Lexapro is FDA-approved for:
In clinical practice, Lexapro is also commonly prescribed off-label for panic disorder, social anxiety disorder, and obsessive-compulsive disorder. Its anxiolytic properties make it a strong choice when anxiety is a prominent feature of a patient's presentation.
One of the clearest differentiators when comparing Wellbutrin vs Lexapro is the anxiety component. Lexapro tends to calm anxiety, while Wellbutrin — because of its activating properties — may not be the best first-line option for patients whose primary concern is anxiety rather than depression.
Side effects are often the deciding factor when choosing between Wellbutrin and Lexapro. While both medications are generally well tolerated, they produce very different side effect profiles because of the neurotransmitters they target.
Weight change is one of the most frequently discussed concerns with antidepressants. Wellbutrin is considered weight-neutral and, in some cases, is associated with modest weight loss. This makes it an appealing option for patients who are concerned about the weight gain that can accompany other antidepressants. Lexapro, like many SSRIs, may cause some weight gain over time, particularly with long-term use, though the effect varies from person to person.
Sexual dysfunction — including decreased libido, difficulty with arousal, and delayed orgasm — is one of the most common reasons patients discontinue SSRIs. Lexapro carries a moderate risk of these side effects. Wellbutrin, by contrast, has a very low rate of sexual side effects and is sometimes added to an SSRI regimen specifically to counteract them. This difference is a significant consideration for many adults weighing Wellbutrin vs Lexapro.
Wellbutrin tends to be activating. Many patients report increased energy, improved concentration, and a greater sense of motivation. However, this stimulating quality can also cause insomnia or restlessness, especially early in treatment or at higher doses. Taking Wellbutrin XL in the morning can help minimize sleep disruption.
Lexapro may cause drowsiness or fatigue in some patients, particularly during the first few weeks. Others find that it has a neutral effect on energy once the body adjusts. Some patients prefer to take Lexapro at bedtime if drowsiness is an issue.
Lexapro is well known for reducing anxiety and is FDA-approved for generalized anxiety disorder. Wellbutrin, on the other hand, can occasionally increase anxiety or jitteriness, particularly at the start of treatment. For patients whose depression includes a strong anxiety component, Lexapro is often the preferred choice.
One important safety consideration specific to Wellbutrin is a dose-dependent increase in seizure risk. At standard therapeutic doses, this risk is low — roughly comparable to other antidepressants. However, the risk rises at higher doses or in patients with a history of seizures, eating disorders, or heavy alcohol use. This is why bupropion has a maximum recommended dose and is contraindicated in certain clinical situations. Lexapro does not carry a notable seizure risk.
Yes — combining Wellbutrin and Lexapro is a well-established strategy in psychiatric practice. Because the two medications target different neurotransmitter systems, they can complement each other effectively. This combination is sometimes referred to as using Wellbutrin as an "augmentation" agent.
Common reasons a psychiatrist may prescribe both medications together include:
This combination is generally considered safe and well tolerated under medical supervision. However, it should only be initiated and managed by a prescribing clinician who can monitor for potential interactions and adjust dosing as needed.
There is no universally "better" medication between Wellbutrin and Lexapro — the right choice depends on the individual's symptom profile, medical history, and personal priorities.
Wellbutrin may be a better fit for adults who:
Lexapro may be a better fit for adults who:
Your psychiatrist will consider all of these factors — along with any other medications you take, your medical history, and your treatment preferences — to determine which medication or combination is the best starting point.
If one medication is not providing adequate relief or is causing intolerable side effects, your psychiatrist may recommend switching from Wellbutrin to Lexapro or vice versa. Because these medications affect different neurotransmitter systems, a direct switch is often possible, though the transition should always be managed by a clinician.
There are several approaches to switching:
It is important not to stop either medication abruptly without medical guidance. Lexapro, in particular, should be tapered gradually to avoid discontinuation symptoms such as dizziness, irritability, and flu-like sensations. Wellbutrin has a lower risk of discontinuation syndrome, but a gradual taper is still recommended when possible.
Lexapro is generally the stronger choice for anxiety. It is FDA-approved for generalized anxiety disorder and has a well-documented calming effect on anxious symptoms. Wellbutrin can sometimes increase anxiety or restlessness, particularly early in treatment, so it is typically not recommended as a first-line option when anxiety is the primary concern.
Wellbutrin is associated with less weight gain than Lexapro. In fact, many patients experience no weight change or even modest weight loss on Wellbutrin. Lexapro may lead to gradual weight gain over time, though this varies significantly between individuals. If weight is a priority in your treatment decision, discuss this with your psychiatrist.
Yes. Combining Wellbutrin and Lexapro is a common and generally safe practice when managed by a psychiatrist. The two medications target different neurotransmitter systems, so they can work together to address a broader range of symptoms. This combination is often used when one medication alone does not fully resolve symptoms or when sexual side effects from Lexapro need to be mitigated.
Both medications typically begin to show initial effects within the first one to two weeks, with more substantial improvement occurring by weeks four to six. Some patients notice changes in energy or sleep patterns earlier, while the full antidepressant effect takes longer to develop. It is important to stay in regular contact with your prescriber during this period so that dosing can be adjusted if needed.
Learn specifically how Prozac works as another SSRI option.
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.If you'd like personalized guidance, schedule an appointment with our team at Elevate Psychiatry. Our board-certified psychiatrists can help you determine whether Wellbutrin, Lexapro, or another approach is the best fit for your needs.
